Shore Capital reiterated their sell rating on shares of J D Wetherspoon (LON:JDW) in a report released on Wednesday, ThisIsMoney.Co.Uk reports.
Several other analysts have also weighed in on JDW. Royal Bank of Canada set a $184.00 price objective on Jazz Pharmaceuticals and gave the company a buy rating in a research note on Monday, March 18th. Peel Hunt reissued a buy rating on shares of Lookers in a research note on Monday, July 8th. Numis Securities initiated coverage on TUI in a research note on Thursday, May 9th. They set a buy rating on the stock. JPMorgan Chase & Co. reissued a neutral rating on shares of Anglo American in a research note on Wednesday, May 15th. Finally, Canaccord Genuity lowered Cronos Group from a hold rating to a sell rating and set a C$17.00 price target on the stock. in a research note on Wednesday, March 27th. Five research analysts have rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company’s stock. J D Wetherspoon presently has a consensus rating of Hold and an average target price of GBX 1,303.13 ($17.03).
LON:JDW opened at GBX 1,460 ($19.08) on Wednesday. The company has a 50-day simple moving average of GBX 1,397.82. The firm has a market capitalization of $1.53 billion and a price-to-earnings ratio of 24.33. The company has a quick ratio of 0.18, a current ratio of 0.26 and a debt-to-equity ratio of 255.30. J D Wetherspoon has a twelve month low of GBX 1,051 ($13.73) and a twelve month high of GBX 1,476 ($19.29).
About J D Wetherspoon
J D Wetherspoon plc owns and operates pubs and hotels in the United Kingdom and the Republic of Ireland. As of July 24, 2017, it operated 895 pubs. The company was founded in 1979 and is headquartered in Watford, the United Kingdom.
Further Reading: Understanding Relative Strength Index
Receive News & Ratings for J D Wetherspoon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for J D Wetherspoon and related companies with MarketBeat.com's FREE daily email newsletter.